Cite
HARVARD Citation
Barrio, S. et al. (n.d.). Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm. British journal of haematology. pp. 667-676. [Online].